{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:30:39Z","timestamp":1770013839134,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T00:00:00Z","timestamp":1450310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.yebeh.2015.12.018","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T11:48:01Z","timestamp":1452772081000},"page":"146-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey"],"prefix":"10.1016","volume":"55","author":[{"given":"Shaloo","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Faught","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Tsong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Forsythe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillipe","family":"Ryvlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2015.12.018_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0967-5868(97)90074-6","article-title":"Relationships within the idiopathic generalized epilepsies","volume":"4","author":"Eadie","year":"1997","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2015.12.018_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0920-1211(94)90080-9","article-title":"Epileptic seizures in 1902 patients: a perspective from a consultant neurological practice (1961\u20131991)","volume":"17","author":"Eadie","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yebeh.2013.05.020","article-title":"Neuropsychological and psychiatric outcomes in poorly controlled idiopathic generalized epilepsy","volume":"28","author":"Sarkis","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0020","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1111\/pme.12542","article-title":"Prevalence of pain reporting and associated health outcomes across emerging markets and developed countries","volume":"15","author":"Goren","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0025","doi-asserted-by":"crossref","first-page":"e86070","DOI":"10.1371\/journal.pone.0086070","article-title":"Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: a patient survey","volume":"9","author":"Dibonaventura","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.2014.863714","article-title":"Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil","volume":"13","author":"Goren","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0050","series-title":"User's manual for the SF-36v2 Health Survey","author":"Maruish","year":"2011"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0055","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/09059180.06.00009801","article-title":"Cost of scheduled and unscheduled asthma management in seven European Union countries","volume":"15","author":"Williams","year":"2006","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0070","author":"Eurostat"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0075","series-title":"Developments in collectively agreed working time 2012","author":"Cabrita","year":"2013"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1528-1167.2006.00595.x","article-title":"Epilepsy care in the world: results of an ILAE\/IBE\/WHO global campaign against epilepsy survey","volume":"47","author":"Dua","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \u201ccommon\u201d neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0175","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1528-1167.2008.01579.x","article-title":"The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a western European country","volume":"49","author":"Picot","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0160","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1007\/s00415-012-6509-3","article-title":"Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany\u2014a nationwide population-based study in children and adults","volume":"259","author":"Hamer","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0180","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/epi.12748","article-title":"Prevalence and incidence of epilepsy in a well-defined population of northern Italy","volume":"55","author":"Giussani","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eplepsyres.2012.05.008","article-title":"Prevalence and clinical characteristics of epilepsy in the south of Spain","volume":"102","author":"Garcia-Martin","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0190","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.seizure.2011.07.011","article-title":"A population-based study of the prevalence and sociodemographic risk factors of self-reported epilepsy among adults in the United Kingdom","volume":"20","author":"Ferro","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0195","doi-asserted-by":"crossref","first-page":"e2480","DOI":"10.1371\/journal.pntd.0002480","article-title":"Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis","volume":"7","author":"Bruno","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0085","first-page":"195-04","article-title":"Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study","volume":"28","author":"Villanueva","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.seizure.2014.01.016","article-title":"Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study)","volume":"23","author":"de Zelicourt","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0095","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2011.03213.x","article-title":"Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review","volume":"52","author":"Taylor","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0100","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1525-5069(02)00503-0","article-title":"Treatment of depressive disorders in epilepsy patients","volume":"3","author":"Gilliam","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0105","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.8_suppl_5.S9","article-title":"Optimizing health outcomes in active epilepsy","volume":"58","author":"Gilliam","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/epi.12913","article-title":"Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial","volume":"56","author":"Jacoby","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0115","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.seizure.2014.06.007","article-title":"Predictors of quality of life and their interrelations in Korean people with epilepsy: a MEPSY study","volume":"23","author":"Lee","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yebeh.2013.09.046","article-title":"Healthcare utilization and costs in adults with stable and uncontrolled epilepsy","volume":"31","author":"Cramer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0125","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/epi.13030","article-title":"A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy","volume":"56","author":"Luoni","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10198-011-0361-8","article-title":"Epilepsy in Sweden: health care costs and loss of productivity\u2014a register-based approach","volume":"13","author":"Bolin","year":"2012","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1528-1167.2010.02946.x","article-title":"The social and economic consequences of epilepsy: a controlled national study","volume":"52","author":"Jennum","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.yebeh.2012.01.021","article-title":"Evaluation of health-care utilization among adult patients with epilepsy in Germany","volume":"23","author":"Strzelczyk","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0145","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/j.1528-1167.2006.00889.x","article-title":"Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany","volume":"47","author":"Hamer","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.0306-5251.2001.01436.x","article-title":"A pharmacoeconomic analysis of the impact of therapeutic drug monitoring in adult patients with generalized tonic\u2013clonic epilepsy","volume":"52","author":"Rane","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yebeh.2012.08.029","article-title":"Health plan paid cost of epilepsy in 2009 in the US","volume":"25","author":"Wilner","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.12.018_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.410370205","article-title":"Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life","volume":"37","author":"Vickrey","year":"1995","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2015.12.018_bb0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.33588\/rn.5707.2013214","article-title":"Aetiology and treatment of epilepsy in a series of 1,557 patients","volume":"57","author":"Torres-Ferr\u00fas","year":"2013","journal-title":"Rev Neurol"},{"issue":"Suppl. S2","key":"10.1016\/j.yebeh.2015.12.018_bb0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/epi.12175","article-title":"Road to refractory epilepsy: the Glasgow story","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2015.12.018_bb0210","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.0000000000000673","article-title":"Treatment outcome after failure of a first antiepileptic drug","volume":"83","author":"Bonnett","year":"2014","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015006733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015006733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T03:58:18Z","timestamp":1748750298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505015006733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":42,"alternative-id":["S1525505015006733"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.12.018","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}